Inactive Instrument
Quest PharmaTech Inc. Stock Other OTC
Stocks
QPTFF
CA74836M1068
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 4.23M 2.98M 2.61M 2.4M 2.23M 283M 4.3M 28.81M 11.21M 140M 11.19M 10.94M 482M | P/E 2025 |
-3.29x | P/E 2026 | 1.18x |
|---|---|---|---|---|---|
| Enterprise Value | 5.21M 3.67M 3.22M 2.96M 2.75M 349M 5.3M 35.53M 13.82M 172M 13.79M 13.5M 595M | EV / Sales 2025 |
-
| EV / Sales 2026 | - |
| Free-Float |
83.12% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -34.61% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 17/06/2004 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 01/01/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 17/06/2004 | |
J. Lievonen
CHM | Chairman | - | 05/07/2021 |
Jeffrey Shon
BRD | Director/Board Member | - | 05/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -34.61% | +0.12% | - | - | 2.98M | |
| -0.80% | +4.21% | +1.94% | +8.34% | 49.74B | |
| +0.25% | +1.70% | +419.39% | +621.71% | 40.49B | |
| -0.16% | +8.42% | +28.20% | +63.00% | 34.35B | |
| +1.10% | +7.77% | +28.18% | -3.96% | 34.75B | |
| +1.31% | -0.56% | +5.12% | +33.90% | 26.98B | |
| -0.35% | +0.09% | - | - | 16.58B | |
| -3.33% | +3.15% | +71.30% | +131.94% | 15.6B | |
| +3.79% | +8.88% | +106.63% | +106.63% | 14.27B | |
| -2.84% | -2.22% | +12.16% | +17.56% | 13.76B | |
| Average | -3.57% | +4.21% | +84.12% | +122.39% | 27.39B | |
| Weighted average by Cap. | -0.02% | +4.59% | +95.52% | +140.69% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.8M -1.27M -1.11M -1.02M -949K -120M -1.83M -12.27M -4.77M -59.45M -4.77M -4.66M -205M | 5M 3.52M 3.08M 2.84M 2.63M 334M 5.08M 34.06M 13.25M 165M 13.22M 12.94M 570M |
| Net Debt | 795K 560K 490K 452K 419K 53.17M 808K 5.42M 2.11M 26.24M 2.1M 2.06M 90.69M | 986K 695K 608K 560K 519K 65.92M 1M 6.72M 2.61M 32.53M 2.61M 2.55M 112M |
Employees
-
Choose MarketScreener 
